Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-09-25FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal (lamotrigine) submitted by GlaxoSmithKline LLC. The approval pertains to a suppleme…
-
FDA approval · 2019-08-26FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2019-08-14FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC.
-
FDA approval · 2019-08-14FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for LAMICTAL (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2019-07-01FDA Approved: HALOPERIDOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for haloperidol lactate (HALOPERIDOL LACTATE) as a generic injectable from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-03-19FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved Zydus Pharmaceuticals USA Inc.'s original application for lurasidone hydrochloride (generic lurasidone).
-
FDA approval · 2019-02-21FDA Approved: ARIPIPRAZOLE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic version of aripiprazole.
-
FDA approval · 2019-01-25FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) from Janssen Pharmaceuticals, Inc., indicating a supplemental app…
-
FDA approval · 2019-01-04FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic lurasidone hydrochloride (an Abbreviated New Drug Application) for the treatment of schizophre…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic lurasidone hydrochloride via an Original Application (ANDA). The generic is indicated for schizophr…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic lurasidone hydrochloride under an Original ANDA, expanding access to this antipsychotic as a gen…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals Inc.'s original application for lurasidone hydrochloride (generic lurasidone) capsules.
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's generic LURASIDONE HYDROCHLORIDE (ANDA) for the same indications as the brand Latuda. These indications include schizo…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Original Application for Lurasidone Hydrochloride (generic lurasidone) for marketing in the U…
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Lithium carbonate ER submitted by Glenmark Pharmaceuticals Inc., USA, representing an approved c…
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate filed by Rising Pharma Holdings, Inc., indicating an approved modification…
-
FDA approval · 2018-12-20FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lithobid (lithium carbonate) from ANI Pharmaceuticals, Inc.
-
FDA approval · 2018-12-20FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate from Hikma Pharmaceuticals USA Inc., a generic drug product.
-
FDA approval · 2018-12-07FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA granted a supplemental approval for Lithium Carbonate from Rising Pharma Holdings, Inc. under ANDA205663.
-
FDA approval · 2018-12-07FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for an extended-release version of lithium carbonate (Lithium Carbonate ER) from Glenmark Pharmaceut…
-
FDA approval · 2018-11-30FDA Approved: LAMOTRIGINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for a generic lamotrigine product.
-
FDA approval · 2018-11-28FDA Approved: VRAYLAR — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for VRYALR (cariprazine) by Allergan, Inc., granting changes to the drug’s labeling.
-
FDA approval · 2018-11-19FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
The FDA approved the original ANDA application for olanzapine, granting generic status to HEC Pharm USA Inc. for this antipsychotic drug.
-
FDA approval · 2018-11-05FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for GEODON (ziprasidone) submitted by Viatris Specialty LLC.